Skip to main content
Loading

Using AI to model ligand binding to target proteins and affinity predictions

06 May 2026
Drug Design & Modeling
  • How reliable are current AI models at predicting ligand binding modes and affinities across diverse target classes
  • What limitations in training data most impact the accuracy of binding and affinity predictions
  • How are teams validating AI predicted binding results against experimental structural and biophysical data
  • Where does AI provide the greatest value in guiding medicinal chemistry decisions versus traditional modeling approaches
  • How can uncertainty in affinity predictions be quantified and communicated to support confident decision making
Industry Expert
Meihua Tu, Director of Computational Chemistry - AstraZeneca